CRISPR Therapeutics AG (CRSP) Cash Flow Annual - Discounting Cash Flows
CRSP
CRISPR Therapeutics AG
CRSP (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
Report Filing: 2025-05-06 2025-02-11 2024-02-21 2023-02-21 2022-02-15 2021-02-16 2020-02-12 2019-02-25 2018-03-08 2017-03-10 2015-12-31 2014-12-31
Net Income/Starting Line -385.7 -366.3 -153.6 -650.2 377.7 -348.9 66.86 -165 -68.36 -23.2 -25.83 -6.8
Cash From Operating Activities -306.5 -142.8 -260.4 -495.7 539 -238.4 56.68 -96.24 -70.1 -55.31 59.43 -4.79
Depreciation and Amortization 19.16 19.26 19.84 24.17 17.95 9.18 4.72 3.52 3.02 0.925 0.127 0.038
Deferred Income Tax 0 0 0 0 0 0 0 4.28 0 -53.71 -0.02 0
Stock Based Compensation 87.37 86.57 81.03 97.95 102.4 66.02 44.06 34.98 18.87 10.84 3.68 0.695
Other Non-Cash Items -3.9 -38.62 -14.04 12.47 14.11 1.86 -10.53 15.41 1.75 8.05 0.097 -0.26
Changes in Working Capital 0.628 156.3 -193.6 19.84 26.86 33.44 -48.43 10.55 -25.39 1.78 81.37 1.53
Accounts Receivable 0 175 -200 0.305 -0.161 -0.045 -0.011 2.54 0.531 -2.82 -0.339 0
Inventory 0 0 23.33 0 -37.51 -25.75 -5.03 332.3 -551.3 -1.09 0 0
Accounts Payable -28.88 0 -20.25 5.16 37.51 25.75 5.03 -323.3 546.6 3.86 0 0
Deferred Revenue 29.5 -18.73 3.33 14.38 27.02 33.48 -48.42 -1 -21.24 1.83 81.71 1.53
Other Working Capital 0 0 0 0 0 0 0 0 0 0 0 0
Cash From Investing Activities -202.4 -280.5 374.6 -258.7 -1,035 -541.2 1.32 -2.77 -8.31 31.88 -1.15 0
Investments in Property Plant and Equipment -1.39 -1.9 -9.47 -37.19 -81.7 -18.36 -6.68 -2.77 -7.81 -3.02 -1.15 0
Payments for Acquisitions 0 0 0 221.5 953.7 522.8 8.01 0 0 -0.1 0 0
Purchases of Securities -1,337 -1,463 -1,066 -1,418 -1,509 -594 0 0 -0.5 -0.1 0 0
Sales and Maturities of Investments 1,157 1,208 1,453 1,196 555.6 71.19 0 0 0 0 0 0
Other Investing Activities -146.6 -23.18 -2.5 -221.5 -953.7 -522.8 8.01 0 -0.5 35 0 0
Cash From Financing Activities 36.64 332 62.66 38.59 250.9 1,016 431 315.9 2.61 183.2 96.73 5.12
Debt Repayment 0 0 0 0 0 0 0 0 0 35.01 38.24 0
Common Stock Issued 28.47 300.7 32.72 0.97 213.3 982.3 415 307.1 2.61 89.06 58.49 0.022
Common Stock Repurchased 0 0 0 0 0 0 0 -0.057 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 8.17 0 29.94 37.62 37.68 33.86 15.96 8.94 2.61 59.15 58.49 5.1
Effect of Forex Changes on Cash 0.031 -0.021 0.073 -0.08 -0.011 0.04 0.015 -0.022 0.041 -0.235 0.009 0.254
Net Change in Cash -237.8 -91.29 177 -715.9 -245.5 236.7 489 216.9 -75.76 159.6 155 0.584
Cash at Beginning of Period 484.5 401.1 224.1 939.9 1,185 948.8 459.8 242.9 315.5 156 0.945 0.361
Cash at End of Period 246.7 309.8 401.1 224.1 939.9 1,185 948.8 459.8 239.8 315.5 156 0.945
Free Cash Flow -307.9 -144.7 -272.3 -532.9 457.3 -256.7 49.99 -99.01 -77.91 -58.33 58.27 -4.79
Operating Cash Flow -306.5 -142.8 -260.4 -495.7 539 -238.4 56.68 -96.24 -70.1 -55.31 59.43 -4.79
Capital Expenditure -1.39 -1.9 -11.97 -37.19 -81.7 -18.36 -6.68 -2.77 -7.81 -3.02 -1.15 0
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us